US regulator approves limited use of malaria drugs for virus  A limited emergency-use authorization for two antimalarial drugs touted as game-changers by President Donald Trump has been issued by the US Food and Drug Administration to treat coronavirus patients .
In a statement published Sunday , the US Department of Health and Human Services detailed recent donations of medicine to a national stockpile -- including chloroquine and hydroxychloroquine , both being investigated as potential COVID-19 treatments .
It said the FDA had allowed them " to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19 , as appropriate , when a clinical trial is not available or feasible .
"  Trump said last week that the two drugs could be a " gift from God , " despite scientists warning against the dangers of overhyping unproven treatments .
Many researchers including Anthony Fauci , the United States ' leading infectious disease expert , have urged the public to remain cautious until larger clinical trials validate smaller studies .
Two US medical bodies -- the National Institutes of Health and the Biomedical Advanced Research and Development Authority -- @ @ @ @ @ @ @ @ @ @ in the scientific community fear Trump 's endorsement of the medicines could create shortages for patients who need them to treat lupus and rheumatoid arthritis , diseases for which they are approved .
The US has more than 140,000 novel coronavirus cases and 2,489 deaths , according to a tracker maintained by Johns Hopkins University .
Citation : US regulator approves limited use of malaria drugs for virus ( 2020 , March 30 ) retrieved 31 March 2020 from https : **39;37;TOOLONG .
This document is subject to copyright .
Apart from any fair dealing for the purpose of private study or research , no part may be reproduced without the written permission .
The content is provided for information purposes only .
E-mail the story  US regulator approves limited use of malaria drugs for virus  Note  Your email address is used only to let the recipient know who sent the email .
Neither your address nor the recipient 's address will be used for any other purpose .
The information you enter will appear in your e-mail message and is not retained by @ @ @ @ @ @ @ @ @ @ Newsletter sign up  Get weekly and/or daily updates delivered to your inbox .
You can unsubscribe at any time and we 'll never share your details to third parties .
Your Privacy  This site uses cookies to assist with navigation , analyse your use of our services , and provide content from third parties .
By using our site , you acknowledge that you have read and understand our Privacy Policy and Terms of Use .
